Brief: Australian Clinical Labs Announces Extension Of Takeover Offer Period For Healius Ltd
Nov 1 (Reuters) - Australian Clinical Labs Ltd ACL.AX :
* TAKEOVER OFFER FOR HEALIUS LIMITED - EXTENSION OF OFFER
PERIOD
* DETERMINED TO FURTHER EXTEND END OF OFFER PERIOD UNTIL
7:00PM
(SYDNEY TIME) ON 29 FEB 2024
* NOTES ACCC HAS NOT PUBLICLY STATED ACL OF DATE ON WHICH
ACCC
EXPECTS TO ANNOUNCE ITS FINAL DECISION FOR PROPOSED MERGER
* RESOLVED TO POSTPONE ACL EGM TO 16 FEBRUARY 2024
Source text for Eikon: ID:nASX9kJcRG
Further company coverage: ACL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million